Hinova Pharma
Chengdu · Founded 2013
About Hinova Pharma
Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptor inhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.
Company Facts
- Founded: 2013
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $219.3M
- Funding stage: IPO
- Last round: Series C (Oct 2020)
- Ticker: sse:688302
- Website: http://www.hinovapharma.com/
- Phone: (028) 8505 8465
Industries & Categories
Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/hinova-pharma-19383 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.